Cargando…

Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes

Lung adenocarcinoma (LUAD) is one of the most widespread and fatal types of lung cancer. Oxidative stress, resulting from an imbalance in the production and accumulation of reactive oxygen species (ROS), is considered a promising therapeutic target for cancer treatment. Currently, immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Guangliang, Huang, Changxin, Zhao, Jiangang, Zhang, Yinghong, Zhao, Wenbin, Dai, Huiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684862/ https://www.ncbi.nlm.nih.gov/pubmed/38017020 http://dx.doi.org/10.1038/s41598-023-47659-8

Ejemplares similares

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma
por: Zhao, Deze, et al.
Publicado: (2022)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
por: Liu, Le-Ping, et al.
Publicado: (2021)

Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma
por: Chang, Xiaoyan, et al.
Publicado: (2022)

Papillary Adenocarcinoma: A Rare Subtype of Lung Adenocarcinoma
por: Thouil, Afaf, et al.
Publicado: (2023)

The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer
por: Cai, Lei, et al.
Publicado: (2020)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
por: Ling, Chen, et al.
Publicado: (2022)

Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma
por: Zhang, Jingchen, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022)

Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes
por: Cao, Peng, et al.
Publicado: (2022)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma
por: Zhu, Yifan, et al.
Publicado: (2022)

DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma
por: Zhao, Yang, et al.
Publicado: (2022)

Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma
por: Li, Ying, et al.
Publicado: (2020)

Effect of autologous NK cell immunotherapy on advanced lung adenocarcinoma with EGFR mutations
por: Hong, Guodai, et al.
Publicado: (2019)

Controversies and challenges in the histologic subtyping of lung adenocarcinoma
por: Butnor, Kelly J.
Publicado: (2020)

Association between histopathological subtype, (18)F-fluorodeoxyglucose uptake and epidermal growth factor receptor mutations in lung adenocarcinoma
por: QIANG, GUANGLIANG, et al.
Publicado: (2016)

Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma
por: Song, Yuqi, et al.
Publicado: (2022)

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma
por: Zhang, Peng, et al.
Publicado: (2022)

The expression of trefoil factor 3 is related to histologic subtypes and invasiveness in lung adenocarcinoma
por: Luo, Wenjuan, et al.
Publicado: (2021)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
por: Zhao, Jian-Gang, et al.
Publicado: (2023)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma
por: Peng, Haijun, et al.
Publicado: (2023)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
por: Wang, Jinsong, et al.
Publicado: (2023)

Multi-omics analysis to identify lung squamous carcinoma lactate metabolism-related subtypes and establish related index to predict prognosis and guide immunotherapy
por: Wang, Chenghao, et al.
Publicado: (2022)

Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma
por: Feng, Caihou, et al.
Publicado: (2022)

Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma
por: Bao, Xuanwen, et al.
Publicado: (2020)

Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma
por: Zhao, Fen, et al.
Publicado: (2022)

Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy
por: Zhang, Xiaotao, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma
por: Yu, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejtvco788o1a644vc09i99887r